FY2025 · ended Dec 31, 2025 · Revenue $3.31B, +6.2% YoY · Filed Mar 2, 2026
Surgery Partners, Inc. (SGRY) files with the SEC under industry code 8062, Services-General Medical & Surgical Hospitals, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.3 billion and a net loss of $77.9 million. Free cash flow was $195.6 million. As of Jun 30, 2026 it held $216.7 million in cash and investments and $4.0 billion in total debt.
Revenue (TTM)
$3.37B
+4.0% vs year-ago TTM
Net income (TTM)
$-88.60M
+50.9% vs year-ago TTM
Operating cash flow (TTM)
$258.00M
-2.2% vs year-ago TTM
Free cash flow (TTM)
$187.60M
+7.0% vs year-ago TTM
EPS (TTM)
$-0.69
+51.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
129.42M
+1.4% vs prior year
Net cash
$-3.74B
as of Jun 30, 2026
Operating margin
11.4%
FY 2026
Company profile
- Industry
- Services-General Medical & Surgical Hospitals, NEC (SIC 8062)
- Listed as
- SGRY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brentwood, TN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1638833
Other Services-General Medical & Surgical Hospitals, NEC companies
- HCA Healthcare, Inc. HCA
- Tenet Healthcare Corp THC
- Universal Health Services Inc UHS
- Ardent Health, Inc. ARDT
- Community Health Systems Inc CYH
All 6 Services-General Medical & Surgical Hospitals, NEC companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $3.3B | $3.1B | $2.7B | $2.5B | $2.2B |
| Operating income | $389.5M | $348.8M | $328.0M | $345.2M | $302.2M |
| Net income | -$77.9M | -$168.1M | -$11.9M | -$54.6M | -$70.9M |
| Diluted EPS | -$0.61 | -$1.33 | -$0.09 | -$0.59 | -$1.12 |
| Operating cash flow | $274.3M | $300.1M | $293.8M | $158.8M | $87.1M |
| Free cash flow | $195.6M | $209.7M | $205.0M | $78.2M | $29.5M |
| Total assets | $8.1B | $7.9B | $6.9B | $6.7B | $6.1B |
| Stockholders' equity | $1.7B | $1.8B | $2.0B | $2.0B | $1.1B |
| Cash and investments | $239.9M | $269.5M | $195.9M | $282.9M | $389.9M |
| Total debt | $5.0B | $4.5B | $3.8B | $3.5B | $3.7B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 26, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
Sep 17, 2026 | Sep 14, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 24, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 5, 2026 |
All 847 Surgery Partners, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.